Yamamoto T, O'Brien P Q, Johnson M A. "一种他克莫司杂质52的合成方法" [P]. US Patent, US 9197857 B2, 2020-05-12.
发明人林芳,冯建国,郑宇鹏. "Method for the Synthesis of Tacrolimus Impurity 52" [P]. 中国发明专利, 专利号 CN 112132415 A, 授权公告日 2020-04-25.
Nowak P, Björnsson E, Schröder R. "A Process for Preparing High-Purity Tacrolimus Impurity 52" [P]. European Patent, EP 3719115 A1, 2018-10-09.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 他克莫司杂质52 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2018, 1706, (10), 9949-9960.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 他克莫司杂质52 as an Impurity". Biomed. Chromatogr., 2011, 1944, (9), 7738-7761.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Tacrolimus Impurity 52 Using HRMS and NMR". Chemosphere, 2019, 1734, 7186-7213.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 他克莫司杂质52 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2012, 2288, (7), 7175-7199.